Skip to content

Daily postoperative eccentric activation - effect on everyday mobility in patients after transcatheter aortic valve Implantation (TAVI)

Daily postoperative eccentric activation - effect on everyday mobility in patients after transcatheter aortic valve Implantation (TAVI) - TAVI-EXZENTRIK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017734
Enrollment
56
Registered
2019-09-25
Start date
2019-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic stenosis

Interventions

Group 1: Intervention group 10 minutes of eccentric activation of large muscle groups of the trunk and lower limb (4 exercises with 15 repetitions each
individualized and progressive
Use of small equipment, training diary) – starting day 2 postoperatively until day of hospital discharge Group 2: Control Patients in the control group received standard care, which consisted of encou

Sponsors

Immanuel Klinikum Bernau, Herzzentrum Brandenburg, Hochschulklinikum der Medizinischen Hochschule Brandenburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adult patients (age > 70 years) - Elective transcatheter aortic valve implantation (TAVI) - No contraindication for light physical training - Ability to understand the scope and importance of the study - written consent to participate in the study

Exclusion criteria

Exclusion criteria: - Emergency intervention - Patient (or representative) is not able to give a written consent for the study participation - acute infection - Diseases that cause physical activity to be contraindicated - post-interventional limitations /complications (ITS duty, respiratory duty, delirium/through syndrome) - treating doctor does not recommend participation in studies *Once an exclusion criterion is met, the patient is not included in the study.

Design outcomes

Primary

MeasureTime frame
Improvement in strength at the time of hospital discharge compared to pre-interventional values

Secondary

MeasureTime frame
health related quality of life assessed as SF-12 and the EuroQol–5 Dimension (EQ5D).

Countries

Germany

Contacts

Public ContactAnja Haase-Fielitz

Immanuel Klinikum Bernau, Herzzentrum Brandenburg, Hochschulklinikum der Medizinischen Hochschule Brandenburg

anja.haase-fielitz@immanuelalbertinen.de03338-694649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026